For Immediate Release
New Consensus on Combination Therapy to Treat Hypothyroidism
Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com
New Rochelle, NY, February 18, 2021—Combination therapy with levothyroxine (LT4) and liothyronine (LT3) is widely used to treat hypothyroidism despite clinical trial results not showing a consistent benefit. A new consensus statement, which presents evidence to support the use of LT4/LT3 combinations and to guide future clinical trial development, is co-published in Thyroid®, the official journal of the American Thyroid Association® (ATA®), and the European Thyroid Journal. Click here to read the statement now.
The consensus statement presents joint discussions from the American Thyroid Association (ATA), British Thyroid Association (BTA), and European Thyroid Association (ETA). It is based on a review of new basic science and clinical evidence regarding combination therapy. Consensus statements were generated regarding the design of future clinical trials of combination therapy.
“We believe that there is equipoise for a new well-designed, adequately powered clinical trial of combination therapy,” stated Jacqueline Jonklaas, MD, PhD, Georgetown University, and coauthors. “Furthermore, patients and physicians have demonstrated an urgent, strong interest in addressing the clinical problem of patients’ dissatisfaction with the existing standard of care for thyroid hormone therapy.”
“This joint statement on combination T3/T4 treatment for hypothyroidism is an important publication that defines the current status of evidence and what gaps in knowledge need to be addressed in the future,” says Electron Kebebew, MD, FACS, Editor-in-Chief of Thyroid, Professor of Surgery, Chief, Division of General Surgery, Harry A. Oberhelman and Mark L. Welton Professor, Stanford University School of Medicine (Stanford, CA).
About the Journal
Thyroid, the official journal of the American Thyroid Association, is an authoritative peer-reviewed journal published monthly online with open access options and in print. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Angela Leung, MD and published monthly, and the groundbreaking videojournal companion VideoEndocrinology, led by Editor William Barry Inabnet, III, MD and published quarterly. Complete tables of content and sample issues may be viewed on the Thyroid website.
Thyroid, the official journal of the American Thyroid Association, is an authoritative peer-reviewed journal published monthly online with open access options and in print. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed on the Thyroid website. The complete Thyroid Journal Program includes the highly valued abstract and commentary publication Clinical Thyroidology®, led by Editor-in-Chief Angela Leung, MD and published monthly, and the groundbreaking videojournal companion VideoEndocrinology, led by Editor William Barry Inabnet, III, MD and published quarterly. Complete tables of content and sample issues may be viewed on the Thyroid website.
About the American Thyroid Association®
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,800 members from 43 countries around the world. Celebrating its 98th anniversary, the ATA delivers its mission — transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; research grant programs for young investigators, biennial clinical and research symposia; support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis, and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,800 members from 43 countries around the world. Celebrating its 98th anniversary, the ATA delivers its mission — transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community — through several key endeavors: the publication of highly regarded professional journals, Thyroid, Clinical Thyroidology, and VideoEndocrinology; annual scientific meetings; research grant programs for young investigators, biennial clinical and research symposia; support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease and thyroid cancer. The ATA promotes thyroid awareness and information through its online Clinical Thyroidology for the Public (distributed free of charge to over 11,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA website serves as the clinical resource for patients and the public who look for reliable information on the Internet.
About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc., publishers is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.